ANTX AN2 Therapeutics Inc

USD 2.40 0.03 1.265823
Icon

AN2 Therapeutics Inc (ANTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.40

+0.03 (+1.27)%

USD 0.07B

0.04M

USD 14.33(+497.22%)

N/A

Icon

ANTX

AN2 Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 2.40
0.00 0
Take a Tour

AN2 Therapeutics Inc (ANTX) Stock Forecast

Show ratings and price targets of :
USD 14.33
(+497.22%)

Based on the AN2 Therapeutics Inc stock forecast from 2 analysts, the average analyst target price for AN2 Therapeutics Inc is USD 14.33 over the next 12 months. AN2 Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AN2 Therapeutics Inc is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, AN2 Therapeutics Inc’s stock price was USD 2.40. AN2 Therapeutics Inc’s stock price has changed by -3.23% over the past week, -27.93% over the past month and -71.80% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...